retatrutide benefits clinical trial retatrutide Eli Lilly's shows promising weight loss results in phase 3 Retatrutide FDA Approval Status 2026:

L.ParkinsonJ

~ AlphaMD Your doctor mentions your PSA came back elevated, and before you can ask a single question, your brain jumps straight to the worst-case scenario

Adverse Effects of GLP-1 Receptor Agonists PMC

These effects may support behavioral change and emotional regulation, potentially bridging pharmacological intervention and long-term psychological improvement

As of late 2025, 23% of US households already have at least one member on a GLP-1 medication, and new patient prescriptions grew 16% between September 2024 and September 2025, representing an additional 2.9 million scripts in a single year

Still, home readings and in-office readings can vary